Cannabis Oil Market Size to Reach USD 7.78 Billion by 2031 | Key Trends, Insights & Forecasts
Cannabis Oil Market Size to Reach USD 7.78 Billion by
2031 | Key Trends, Insights & Forecasts
Global cannabis oil market is
undergoing an unprecedented transformation, driven by expanding medical
adoption, regulatory progress, and growing consumer preference for organic
wellness products. The market, valued at USD 1.21 billion in 2024, is
projected to grow to USD 1.59 billion in 2025 and reach USD 7.78
billion by 2031, reflecting an extraordinary CAGR of 31.3% during
the forecast period.
Access the full report https://www.24lifesciences.com/cannabis-oil-market-8036
Emerging
Healthcare Trends Reshaping the Cannabis Oil Market
The cannabis oil market is being
propelled by notable 2025 healthcare trends, particularly the shift towards
natural therapeutics, patient-centric care, and clinical validation of plant-based
medicine.
Several macro-trends are reshaping the industry:
- Rising adoption of cannabis-based medical treatments for chronic pain, epilepsy, mental health, and
cancer-related symptoms.
- Growing preference for organic and full-spectrum oils, aligning with clean-label wellness trends.
- Expansion of evidence-based research, supported by increasing publications in clinical
journals such as PubMed (external link: https://pubmed.ncbi.nlm.nih.gov).
- Digitization of retail channels, where online platforms and dispensaries are becoming
major consumer access points.
- Regulatory liberalization, improving product quality standards and accelerating
product approvals across global markets.
These dynamics reflect a broader
shift toward integrated, alternative, and evidence-backed health systems.
Key
Market Drivers
- Technological integration in extraction &
formulation: Advanced CO₂ extraction and
nanotechnology-enhanced delivery systems are improving purity, bioavailability,
and therapeutic outcomes.
- Medical legalization and physician adoption: More countries are approving cannabis-based therapies,
supporting clinical integration and patient access.
- Growing consumer demand for natural, chemical-free
solutions: Organic cannabis oil continues
to gain momentum due to perceived higher safety and efficacy.
- Rise of dispensary-led education models: Personalized consultation and regulatory compliance
are strengthening consumer confidence.
- Expanding research funding: Increased global R&D investment into cannabinoid
therapy is creating new treatment pathways in neurology, oncology, and
chronic disease management.
Download the complete study https://www.24lifesciences.com/download-sample/8036/cannabis-oil-market
Competitive
Landscape: Leading Companies Driving Market Innovation
Leading cannabis oil companies are
expanding their product portfolios, strengthening regulatory compliance, and
exploring global partnerships to capitalize on the fast-growing demand.
Key players include:
- Select Oil
– Continues to expand premium-grade product offerings, with a focus on
full-spectrum formulations.
- K.I.N.D. Concentrates
– Increasing investment in terpene-rich medical oils and advanced
extraction technologies.
- Canopy Growth Corporation – Expanding global medical cannabis distribution and
research collaborations.
- Aphria (Tilray Brands) – Accelerating product innovation in
pharmaceutical-grade cannabis oils.
- Emblem Cannabis Oils
– Enhancing patient-focused formulations with standardized dosing for
medical programs.
These players are differentiating
through product purity, clinical alignment, and consumer trust-building
initiatives.
Segment
Insights & Regional Overview
By
Type
- Organic Cannabis Oil (Leading Segment): Dominates due to the global shift toward
chemical-free, natural health products. Its premium positioning enables
strong brand loyalty and higher pricing.
- Non-Organic Cannabis Oil: Remains relevant for cost-sensitive markets.
By
Application
- Medical Use (Dominant): The strongest segment, supported by scientific
validation for chronic pain, anxiety, seizure disorders, and cancer
symptom therapy.
- Recreational & Others: Growing steadily with changing social acceptance.
By
End User
- Individual Consumers (Largest Share): Driven by convenience, wellness trends, and online
retail proliferation.
- Hospitals & Clinics / Research Institutions: Reinforced by structured treatment programs and
clinical trials.
By
Distribution Channel
- Dispensaries (Leading): Offer expert guidance, compliance, and trust—critical
in a legally complex industry.
- Online Retail & Pharmacies: Gaining strong momentum as awareness increases.
By
Product Form
- Full-Spectrum Oil (Leading): Favored due to the “entourage effect” that enhances
therapeutic outcomes.
- Broad-Spectrum & Isolate Oils: Serve specific medical and regulatory needs.
Get
the full insights https://www.24lifesciences.com/cannabis-oil-market-8036
Regional
Market Highlights
North
America (Global Leader)
With mature regulations, high
consumer awareness, and significant research infrastructure, North America
dominates the global cannabis oil market. The U.S. remains the largest
individual market, while Canada’s federally regulated system supports
innovation and exports.
Europe
A primarily medical-driven market
experiencing rapid adoption in Germany, the U.K., and the Netherlands.
GMP-certified production facilities enhance quality and trust.
Asia-Pacific
Restrictive but high-potential
region. Early adopters include Australia, Thailand, and South Korea, while
cultural barriers persist in major economies.
South
America
Emerging rapidly due to progressive
legalization in Uruguay, Colombia, and Brazil, combined with ideal cultivation
conditions.
Middle
East & Africa
Still in the early stages, with
progress primarily in Israel and South Africa. Long-term growth depends on
legislative reform.
Can
AI-Driven Care Models Reshape the Future of Cannabis-Based Medicine?
AI-powered analytics, genomics, and
digital therapeutics are beginning to play a transformative role in optimizing
cannabinoid-based treatments.
Future models may include:
- Personalized cannabis therapy based on genetic markers
- AI-integrated dosing recommendations
- Predictive analytics for treatment efficacy and safety
- Technology-enabled patient monitoring platforms
This convergence of biotechnology
and digital health will likely redefine medical cannabis adoption.
Key
Benefits of the Report
- Comprehensive segmentation and regional deep-dive
- Market sizing, value forecasts, and CAGR projections
- Competitive benchmarking of top global companies
- Investment opportunities in emerging cannabinoid
therapies
- Insights into technological innovations redefining
market growth
Explore the detailed report https://www.24lifesciences.com/cannabis-oil-market-8036
Future
Perspective
As global healthcare shifts toward
natural, research-backed, and personalized therapeutic solutions, the cannabis
oil market presents exceptional long-term growth potential. Stakeholders
aligned with regulatory evolution, R&D innovation, and consumer-centric
product development are positioned to benefit the most from this rapidly
expanding landscape.
Explore
Life sciences Related Ongoing Coverage in Healthcare Domain:
Adhesives
for Wearable Medical Device Market
Acetylcysteine
API Market Regional
Vital
Signs Monitoring Devices Market
Blood
Infection Testing Market
Hypromellose
Acetate Succinate Market
Biometric
Technology Market
Gelatin
Capsule Market Regional
In-Ear
Digital Hearing Aid Market
Man-made
Vascular Graft Market
About 24lifesciences
Founded in 2017, 24LifeScience has emerged
as a trusted research and analytics partner for organizations operating within
the global life sciences and chemical industries. Our core mission is to
provide intelligent, future-ready insights that help clients stay ahead in an
increasingly complex and innovation-driven market
International: +1(332) 2424 294 | Asia: +91 9425150513 (Asia)
Website: http://www.24lifesciences.com
Follow us on
LinkedIn: http://www.linkedin.com/company/lifesciences24
.jpg)
Comments
Post a Comment